Loading organizations...
Fountainhead Partnerships operates an equity fund tailored for accredited investors, focusing on a multi-thematic, quality, and growth-oriented investment strategy. The firm specializes in identifying and investing in sustainable businesses that stand to benefit from global secular trends, while proactively managing market risk through active hedging. Its investment philosophy emphasizes disciplined, long-term capital preservation and compounding.
The company was founded by Asif Ali, who began deploying its core strategy in 2015. Ali's founding insight stemmed from the conviction that enduring success in long-term investing demands not only patience akin to a business owner but also the temperament to skillfully navigate market volatility and overcome inherent behavioral biases. This approach forms the bedrock of their fund's design.
Fountainhead Partnerships serves accredited investors seeking a thoughtful and patient approach to capital growth. The firm's long-term vision is centered on continuous value creation, aiming to preserve and significantly compound capital by adhering to its strategic investment principles across diverse global themes. The focus remains on robust, sustainable enterprises.
Fountainhead Partners has 1 tracked investment across 1 company. The latest tracked deal is $170.0M Series B in AffaMed Therapeutics in March 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 30, 2021 | AffaMed Therapeutics | $170.0M Series B | BIN LI | WEI FU, Orion Science Capital, Partners Investment, Superstring Capital |